COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government's top infectious diseases expert said on Thursday.
FILE PHOTO: Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a Senate Health, Education, Labor and Pensions Committee hearing on efforts to get back to work and school during the coronavirus disease outbreak, in Washington, D.C., U.S. June 30, 2020. Al Drago/Pool via REUTERS
- COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government’s top infectious diseases expert said on Thursday. The news comes as Moderna Inc, which is at the forefront of the country’s vaccine development efforts, reiterated earlier in the day that a late-stage trial with 30,000 volunteers would begin this month.
“We may be able to at least know whether we are dealing with a safe and effective vaccine by the early winter, late winter, beginning of 2021,” Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said in an interview to JAMA Network. Earlier on Thursday, Dr. Francis Collins, the director of the U.S. National Institutes of Health, said the Trump administration’s vaccine-acceleration program could generate a safe and effective COVID-19 vaccine by year-end.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Meghan McCain Doesn't Trust Dr. Fauci Because He Didn't Blame Protesters for Covid-19 UptickMeghan McCain said on The View on Wednesday that while she is worried about the rise in covid-19 cases, she’s lost trust in Dr. Anthony Fauci because he isn’t “screaming bloody murder” about Black Lives Matter protests and Pride marches.
Lire la suite »
Fauci: Covid-19 Vaccine Safety And Effectiveness Should Be Known ‘By Early Winter’Dr. Anthony Fauci said the safety and effectiveness of a vaccine for the coronavirus strain Covid-19 should be known by “early winter” with 200 million doses available for U.S. use by early 2021.
Lire la suite »
Factbox: COVID-19 vaccine candidates with early human-trial dataA COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.
Lire la suite »
U.S. becoming further isolated by COVID-19 crisisAmerica&39;s coronavirus death toll has climbed to nearly 127,000, and the European Union lifted travel restrictions for 15 countries but not the U.S.
Lire la suite »
7.8 million Brazilians out of work due to Covid-19Nearly eight million people in Brazil have lost work due to the coronavirus pandemic, according to new figures released by the country's statistics agency Tuesday.
Lire la suite »